NTQ-6179

N/A

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameNTQ-6179
Drug Alias NameNTQ-6179
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 2 modulators
TargetsSomatostatin receptor 2
Therapy Area/IndicationsAcromegalyNeuroendocrine Tumors
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsAcromegalyNeuroendocrine Tumors
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A